Autologous ex vivo–expanded tumor-infiltrating lymphocytes that recognize tumor antigens via their endogenous T-cell receptors engaging peptide–MHC on tumor cells, mediating antigen-specific cytotoxicity through perforin/granzyme release and cytokine secretion, leading to targeted tumor cell killing and immune amplification within the tumor microenvironment.